Influence of race on kidney transplant survival.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMID 325754)

Published in Transplant Proc on March 01, 1977

Authors

G Opelz, M R Mickey, P I Terasaki

Articles citing this

The point system for organ distribution. Transplant Proc (1989) 1.88

Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res (2013) 1.46

Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg (2016) 1.39

Renal transplantation in black recipients at the University of Pittsburgh. Transplant Proc (1989) 1.19

Effect of donor ethnicity on kidney survival in different recipient pairs: an analysis of the OPTN/UNOS database. Transplant Proc (2009) 1.09

Important risk factors of allograft survival in cadaveric renal transplantation. A study of 426 patients. Ann Surg (1988) 1.03

What causes center effects in kidney transplantation. Ann Surg (1986) 1.01

The role of various risk factors in living related donor renal transplant success. Ann Surg (1980) 0.94

Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol (2014) 0.88

Effect of splenectomy on first cadaver kidney transplants. Ann Surg (1980) 0.86

Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients. Transplantation (2016) 0.80

Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Transplantation (2016) 0.78

Outcome after renal transplantation in children from native and immigrant families in Austria. Eur J Pediatr (2008) 0.77

Gene expression profiling to study racial differences after heart transplantation. J Heart Lung Transplant (2015) 0.77

Twenty years of evolving trends in racial disparities for adult kidney transplant recipients. Kidney Int (2016) 0.76

High risk factors in transplantation. Ulster Med J (1985) 0.75

Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension (2016) 0.75

Articles by these authors

High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90

Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88

Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50

Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80

Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40

Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22

Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52

Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet (1995) 2.50

Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48

Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40

Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33

SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25

Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23

The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13

Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant (2013) 2.12

Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12

Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11

Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09

Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06

Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02

[Immunological aspects of kidney transplantation in Switzerland 1981-1992. Swiss Transplant Work Group Kidney Transplantation]. Schweiz Med Wochenschr (1995) 1.91

Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89

Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89

A semimicro mixed leukocyte culture test. Transplantation (1971) 1.85

Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet (1988) 1.82

Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids. J Natl Cancer Inst (1973) 1.79

Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78

Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70

DNA damage and repair in female C57BL/10 mice of different ages injected with the carcinogen benzo[a]pyrene-trans-7,8-diol. Mutat Res (1989) 1.68

Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67

Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65

Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63

Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63

Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation (1973) 1.60

Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60

Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58

Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58

Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58

Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57

HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56

Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56

Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis (1974) 1.55

Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54

Impaired in-vitro lymphocyte responses in patients with elevated pentachlorophenol (PCP) blood levels. Arch Environ Health (1995) 1.52

Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50

HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49

HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet (1980) 1.46

Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation (1970) 1.46

HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45

Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45

Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant (2013) 1.44

Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43

Evaluation of HLA matching for CREG antigens in Europe. Transplantation (1999) 1.43

Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43

Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant (2007) 1.43

Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant (2009) 1.43

Twins with two different fathers identified by HLA. N Engl J Med (1978) 1.43

HLA DNA typing and transplantation. Immunity (2001) 1.42

LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATION. Ann N Y Acad Sci (1996) 1.42

HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med (1974) 1.41

Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet (1974) 1.40

HLA matching assessed from early graft function. Transplant Proc (1987) 1.40

Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40

Lymphocyte abnormalities in ankylosing spondylitis. Ann Rheum Dis (1977) 1.39

IL-6 independent monocyte/B cell defect in renal transplant recipients with long-term stable graft function. Transplantation (1994) 1.39

Serotyping for homotransplantation. XIX. Experience with an interhospital scheme of cadaver-kidney sharing and tissue typing. JAMA (1969) 1.38

Genetics of four new HL-A specificities in the Caucasian and Negro populations. Transplant Proc (1971) 1.38

Analyses of the UNOS Scientific Renal Transplant Registry at three years--early events affecting transplant success. Transplantation (1992) 1.37

HLA-B14 antigen and postencephalitic Parkinson's disease. Their association in an American-Jewish ethnic group. Arch Neurol (1980) 1.37

Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood (1977) 1.35

Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol (1999) 1.34